MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/cid/ciy1070

Медицинская библиотека · Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2019

Does Tenofovir-containing First-line Antiretroviral Therapy Mitigate the Impact of Pretreatment Non-nucleoside Reverse Transcriptase Inhibitor Drug Resistance?

Inzaule Seth C, Rinke de Wit Tobias F, Hamers Raph L, Pan-African Studies to Evaluate Resistance

Письмо в редакциюПоддержка исследования: вне правительства СШАКомментарийПеревод в очереди

Аннотация

Redox homeostasis is a critical part of physiological processes. Disruption of such homeostasis is associated with various pathological conditions. Tools for studying cellular redox states are important for understanding various biological mechanisms and for the targeted delivery of drugs and/or imaging agents. Along this line, there have been reaction-based fluorescent probes capable of detecting either oxidative stress or hypoxia. However, tools are not available to detect dynamic redox changes in either direction. Toward that end, we describe chemistry that allows for detecting both reduction and oxidation changes using a probe redox pair, moving toward monitoring dynamic redox processes. Embedded in this new approach is also new chemistry for fluorophore activation through the selective reduction of a sulfone group to a thioether under severe hypoxia, complementing the widely used nitro or N-oxide reduction approaches. We demonstrate the feasibility through solution-phase studies and cell-culture work in two cell lines: cancer cells and macrophages. One optimized redox probe pair was studied for its response to both induction of highly reactive oxygen species (hROS) production by turning off the fluorescence and severe hypoxia with fluorescence turn-on. Overall, this approach sets a new direction in designing redox-sensitive tools.

Для цитирования: Inzaule Seth C, Rinke de Wit Tobias F, Hamers Raph L, Pan-African Studies to Evaluate Resistance. Does Tenofovir-containing First-line Antiretroviral Therapy Mitigate the Impact of Pretreatment Non-nucleoside Reverse Transcriptase Inhibitor Drug Resistance?. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2019. DOI: 10.1093/cid/ciy1070.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.